Raymond James & Associates’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $10.2M | Buy |
141,907
+58,663
| +70% | +$4.22M | 0.01% | 1223 |
|
|
2024
Q2 | $5.77M | Sell |
83,244
-1,391
| -2% | -$96.4K | ﹤0.01% | 1480 |
|
|
2024
Q1 | $6.78M | Buy |
84,635
+4,231
| +5% | +$339K | ﹤0.01% | 1379 |
|
|
2023
Q4 | $8.8M | Sell |
80,404
-2,555
| -3% | -$280K | 0.01% | 1180 |
|
|
2023
Q3 | $8.37M | Buy |
82,959
+2,131
| +3% | +$215K | 0.01% | 1149 |
|
|
2023
Q2 | $11M | Sell |
80,828
-22,165
| -22% | -$3.01M | 0.01% | 992 |
|
|
2023
Q1 | $10.7M | Buy |
102,993
+10,259
| +11% | +$1.07M | 0.01% | 987 |
|
|
2022
Q4 | $8.22M | Sell |
92,734
-3,383
| -4% | -$300K | 0.01% | 1109 |
|
|
2022
Q3 | $7.71M | Sell |
96,117
-8,136
| -8% | -$652K | 0.01% | 1105 |
|
|
2022
Q2 | $9.98M | Sell |
104,253
-930
| -0.9% | -$89.1K | 0.01% | 980 |
|
|
2022
Q1 | $15.6M | Buy |
105,183
+2,309
| +2% | +$343K | 0.01% | 830 |
|
|
2021
Q4 | $14.6M | Sell |
102,874
-695
| -0.7% | -$98.5K | 0.01% | 905 |
|
|
2021
Q3 | $13.6M | Buy |
103,569
+11,532
| +13% | +$1.51M | 0.01% | 898 |
|
|
2021
Q2 | $12.6M | Buy |
92,037
+16
| +0% | +$2.2K | 0.01% | 947 |
|
|
2021
Q1 | $12M | Buy |
92,021
+4,612
| +5% | +$602K | 0.01% | 923 |
|
|
2020
Q4 | $9.79M | Buy |
87,409
+2,307
| +3% | +$258K | 0.01% | 963 |
|
|
2020
Q3 | $6.7M | Sell |
85,102
-2,182
| -2% | -$172K | 0.01% | 1061 |
|
|
2020
Q2 | $6.28M | Buy |
87,284
+12,032
| +16% | +$866K | 0.01% | 1060 |
|
|
2020
Q1 | $4.31M | Buy |
75,252
+28,177
| +60% | +$1.61M | 0.01% | 1124 |
|
|
2019
Q4 | $5.26M | Buy |
47,075
+885
| +2% | +$99K | 0.01% | 1206 |
|
|
2019
Q3 | $4.44M | Buy |
46,190
+4,914
| +12% | +$472K | 0.01% | 1301 |
|
|
2019
Q2 | $3.53M | Buy |
41,276
+13,107
| +47% | +$1.12M | 0.01% | 1443 |
|
|
2019
Q1 | $2.34M | Buy |
+28,169
| New | +$2.34M | ﹤0.01% | 1662 |
|